Tvardi Therapeutics, Inc. (TVRD)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-07-07 | Tweardy Samuel David | ten percent owner | J | 315,658 | 0 | $0 |
| 2025-07-07 | Tweardy Samuel David | ten percent owner | J | 315,658 | 0 | $0 |
| 2025-04-15 | HALL WALLACE L JR | director | A | 44,712 | — | — |
| 2025-04-15 | HALL WALLACE L JR | director | A | 202,044 | — | — |
| 2025-04-15 | Wirk Shaheen | director | A | 263,164 | — | — |
| 2025-04-15 | Wirk Shaheen | director | A | 176,030 | — | — |
| 2025-04-15 | HALL WALLACE L JR | director | J | 202,044 | — | — |
| 2025-04-15 | HALL WALLACE L JR | director | J | 44,712 | — | — |
| 2025-04-15 | Wirk Shaheen | director | A | 4,191 | — | — |
| 2025-04-15 | Wirk Shaheen | director | J | 263,164 | — | — |
| 2025-04-15 | Wirk Shaheen | director | J | 176,030 | — | — |
| 2025-02-28 | Posner Christopher | director | S | 583 | 4.75 | $2,769 |
| 2025-02-28 | Terrillion Scott | officer | S | 163 | 4.76 | $776 |
| 2025-02-04 | Posner Christopher | director | S | 372 | 4.72 | $1,756 |
| 2024-11-04 | Posner Christopher | director | S | 3,668 | 0.29 | $1,064 |
| 2024-08-01 | Posner Christopher | director | S | 4,149 | 0.35 | $1,452 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.